Suppression of thyrotropic hormone secretion by prostaglandin synthesis inhibitors.
In order to determine whether endogenous prostaglandins (PGs) are involved in the secretion of thyrotropic hormone (TSH), we monitored plasma TSH levels in female rats receiving indomethacin (Ind) or aspirin (Asp) to inhibit PG synthesis. TSH secretion was induced by either exogenous thyrotropin-releasing hormone (TRH) or by throidectomy. On the basis of preliminary experiments, Ind was found to inhibit thyroid secretion directly. Subsequently, thyroidectomized rats receiving thyroxine (T4) replacement (2-4 mug/100 g BW/day) were used to avoid this complicating factor. These replacement regimens were judged to be adequate on the basis of the measurement of plasma triiodothyronine and T4 levels, and the lack of a compensatory rise in plasma TSH levels. Under these conditions, Ind significantly inhibited, but did not abolish, the TSH response to exogenous TRH (250 ng/100 g BW iv). Thyroidectomy-induced TSH secretion was abolished by Ind, and could be reversed upon cessation of Ind treatment. Aspirin was also found to inhibit significantly the compensatory TSH rise following thyroidectomy. These findings suggest that endogenous pituitary PGs mediate the stimulation of TSH secretion by TRH or by reduced feedback of thyroid hormones.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D005246:Feedback; D005260:Female; D007213:Indomethacin / Q000494:pharmacology*; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism; D011448:Prostaglandin Antagonists / Q000494:pharmacology*; D011453:Prostaglandins / Q000502:physiology*; D051381:Rats; D013961:Thyroid Gland / Q000502:physiology; D013972:Thyrotropin / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D001241:Aspirin; D007213:Indomethacin